Balance Sheet Data

Viracta Therapeutics, Inc. (VIRX)

$0.489

-0.01 (-1.21%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 13.7029.1347.09103.5591.041,432.206,305.0427,757.07122,196.65537,953.80
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 1.390.791.562.902.5452.87232.741,024.614,510.6919,857.70
Accounts Payable (%)
Capital Expenditure ---0.05-4.25-0.04-29.10-128.11-563.97-2,482.79-10,930.12
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.